70
Views
4
CrossRef citations to date
0
Altmetric
Review

Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination

&
Pages 21-30 | Published online: 19 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Randell Wexler, Adam Pleister, Subha V. Raman & James R. Borchers. (2012) Therapeutic Lifestyle Changes for Cardiovascular Disease. The Physician and Sportsmedicine 40:1, pages 109-115.
Read now
Valentina Forni, Grégoire Wuerzner, Menno Pruijm & Michel Burnier. (2011) Long-term use and tolerability of irbesartan for control of hypertension. Integrated Blood Pressure Control 4, pages 17-26.
Read now

Articles from other publishers (2)

Satoshi Miyazaki, Tetsushi Sakuragi, Toshihiro Hamada, Shinobu Sugihara, Daeho Park, Kazuoki Inoue, Einosuke Mizuta, Yasutaka Yamamoto, Akira Ohtahara, Masanari Kuwabara, Hiromi Sakaguchi, Yoshihito Nozaka, Senzou Kishida, Kazuhide Ogino, Masahiko Kato, Shin-ichi Taniguchi, Akio Yoshida, Haruaki Ninomiya, Kazuhiro Yamamoto & Ichiro Hisatome. (2018) Effects of Irbesartan on Uric Acid Metabolism in Patients with Treated Essential Hypertension. Vascular Failure 2:1, pages 11-19.
Crossref
Hongmei Li, Xiaohong Zhu, Aili Wang, Guiyan Wang & Yonghong Zhang. (2012) Co-effect of insulin resistance and biomarkers of inflammation and endothelial dysfunction on hypertension. Hypertension Research 35:5, pages 513-517.
Crossref